Clinical Efficacy and Mechanism Research of Getong Tongluo Capsule in Ischemic Stroke | MicrobiomeTrials← Back to trialsNCT07690020
Clinical Efficacy and Mechanism Research of Getong Tongluo Capsule in Ischemic Stroke
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-08-01Est. Completion: 2029-07-31
Enrollment target: 216 participants Other microbiome trials you might be interested in
Atrial Fibrillation (AF)
The goal of this clinical trial is to learn if the cardiac pulsed field ablation system, composed of the cardiac pulsed …
Multiple LocationsEst. completion Mar 2028
Arteriosclerosis Obliterans
This study is a prospective, single-center, observational study. In this study, we aim to evaluate the clinical outcome …
Guangzhou, ChinaEst. completion Jul 2027
Intracerebral Hemorrhage
Stroke
Stroke, Acute
Stroke, Ischemic
Stroke Hemorrhagic
Stroke (CVA) or TIA
Brain Diseases
Background Reperfusion therapies, i.e., intravenous thrombolysis (IVT) and/or endovascular thrombectomy (EVT), are most …
Hong Kong, Hong KongEst. completion Dec 31, 2027